What actually slows your epigenetic clock? A landmark trial has an answer — and it isn’t a supplement alone

Epigenetic clocks — which estimate biological age from patterns of DNA methylation — have mostly lived in observational research: measuring who is aging fast or slow, without a clean randomised test of whether a specific intervention can shift the clock itself. A 2025 Nature Aging paper, co-authored by Steve Horvath (who invented the original epigenetic clock), changes that.

What DO-HEALTH tested

DO-HEALTH was a large factorial randomised controlled trial in adults aged 70 and older, testing vitamin D (2,000 IU/day), omega-3 (1g/day) and a simple home strength-exercise program, alone and in every combination, against placebo/control. This 2025 paper is a post-hoc analysis applying four separate DNA methylation clocks to 777 of the original participants’ blood samples.

What they found

Each of the three interventions independently slowed biological aging on at least one clock relative to control, and the combination of all three (vitamin D + omega-3 + exercise) produced the largest effect — consistent with additive rather than redundant benefit across the three, quite different mechanisms.

"These findings support the DO-HEALTH trial’s primary endpoints and suggest that vitamin D, omega-3 and a simple exercise program have a favorable effect on aging at a molecular level" — adapted from the study’s reported conclusions

The caveats worth keeping in mind

This is a post-hoc secondary analysis — the original DO-HEALTH trial was not designed with epigenetic aging as its primary endpoint, and the sample analysed here (777 of the full cohort) is a subset. Effect sizes on the clocks were modest, and the population studied was adults 70+, so direct extrapolation to younger adults deserves some caution. It is nonetheless one of the cleaner randomised human demonstrations that all three inputs are independently doing something at the molecular level, not just correlating with better health.

All three levers tested here — vitamin D status, omega-3 intake and resistance-style exercise — are already core parts of Misi’s Longevity habit stack and biomarker tracking, which is exactly the kind of trial that validates continuing to prioritise them.